|
|
March 22-24, 2024 | Multitumor CME-MOC/NCPD Symposium | Miami, Florida
Third Annual National General Medical Oncology SummitA Multitumor CME/MOC- and NCPD-Accredited Educational Conference Developed in Partnership with Florida Cancer Specialists and Research Institute
Dates
March 22–24, 2024 Location JW Marriott Miami Turnberry 19999 West Country Club Drive Aventura, Florida Hotel Phone: (305) 932-6200 Meeting Room King Ballroom (Conference Level)
This event will also be webcast live.
Please see Registration tab for details. Room Reservations A special discounted room rate of $399 (plus applicable tax and resort fee) is available to conference attendees at JW Marriott Miami Turnberry. Please see the Location tab for details. Note from the Moderator This coming March will mark the return of our Annual Miami General Medical Oncology Symposium. I am also pleased to announce that we will be partnering with Florida Cancer Specialists and Research Institute for this one-of-a-kind offering that will span 3 days and feature a stellar multidisciplinary faculty panel of clinical investigators and a unique blend of short didactic presentations, lively moderated panel discussions and dedicated Q&A sessions. The conference’s educational design and the topics that will be discussed offer interested clinicians the opportunity to access the in-depth perspectives of some of the top minds in the field regarding significant new data sets, promising treatment strategies and key interdisciplinary management considerations in the care of patients with cancer. So as you begin to make your plans for 2024, we hope you will include joining us in sunny South Florida for a learning experience unlike any other out there. Additional information, including participating faculty, will be made available in the coming months.
Breast Cancer
Erika Hamilton, MD Director, Breast Cancer Research Program Sarah Cannon Research Institute Nashville, Tennessee Kevin Kalinsky, MD, MS Associate Professor Department of Hematology and Medical Oncology Emory University School of Medicine Director, Glenn Family Breast Center Director, Breast Medical Oncology Winship Cancer Institute of Emory University Atlanta, Georgia Joyce O’Shaughnessy, MD Celebrating Women Chair in Breast Cancer Research Baylor University Medical Center Director, Breast Cancer Research Program Texas Oncology US Oncology Dallas, Texas Hope S Rugo, MD Professor of Medicine Winterhof Family Professor of Breast Cancer Director, Breast Oncology and Clinical Trials Education Medical Director, Cancer Infusion Services University of California, San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco, California Colorectal Cancer Kristen K Ciombor, MD, MSCI Associate Professor of Medicine Division of Hematology/Oncology Vanderbilt-Ingram Cancer Center Nashville, Tennessee John Strickler, MD Associate Professor Duke University Durham, North Carolina Gastroesophageal Cancers Yelena Y Janjigian, MD Chief of Gastrointestinal Oncology Service Department of Medicine Memorial Sloan Kettering Cancer Center New York, New York Samuel J Klempner, MD Associate Professor Massachusetts General Hospital Harvard Medical School Boston, Massachusetts Gynecologic Cancers David M O'Malley, MD Director and Professor Division of Gynecologic Oncology in Obstetrics and Gynecology John G Boutselis Chair in Gynecologic Oncology The Ohio State University and The James Comprehensive Cancer Center Columbus, Ohio Additional faculty to be announced Hepatobiliary Cancers Ghassan Abou-Alfa, MD, MBA Attending Memorial Sloan Kettering Cancer Center Professor Weill Cornell Medical College at Cornell University Adjunct Professor Trinity College Dublin (Ireland) New York, New York Richard S Finn, MD Professor, Department of Medicine, Division of Hematology/Oncology David Geffen School of Medicine at UCLA Director, Signal Transduction and Therapeutics Program Jonsson Comprehensive Cancer Center Los Angeles, California Hodgkin and Non-Hodgkin Lymphoma Ann S LaCasce, MD, MMSc Director, Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology Associate Professor of Medicine Harvard Medical School Lymphoma Program Dana-Farber Cancer Institute Boston, Massachusetts Matthew Lunning, DO Associate Professor of Medicine Medical Director, Cellular Therapy Associate Vice Chair of Research Assistant Vice Chancellor for Clinical Research Division of Hematology/Oncology Department of Internal Medicine University of Nebraska Medical Center Omaha, Nebraska Andrew D Zelenetz, MD, PhD Medical Director, Quality Informatics Attending Physician Memorial Sloan Kettering Cancer Center Professor of Medicine Weill Cornell Medical College New York, New York Additional faculty to be announced
Lung Cancer
Ibiayi Dagogo-Jack, MD Assistant Professor of Medicine Harvard Medical School Massachusetts General Hospital Boston, Massachusetts Edward B Garon, MD, MS Professor David Geffen School of Medicine at UCLA Director, Thoracic Oncology Program Director, Signal Transduction and Therapeutics Program Jonsson Comprehensive Cancer Center Los Angeles, California Corey J Langer, MD Director of Thoracic Oncology Abramson Cancer Center Professor of Medicine Perelman School of Medicine University of Pennsylvania Philadelphia, Pennsylvania Helena Yu, MD Medical Oncologist Associate Attending Memorial Sloan Kettering Cancer Center New York, New York Multiple Myeloma Natalie S Callander, MD Director, Myeloma Clinical Program Interim Director, Bone Marrow Transplant Program University of Wisconsin Carbone Cancer Center Madison, Wisconsin Paul G Richardson, MD Clinical Program Leader and Director of Clinical Research Jerome Lipper Multiple Myeloma Center Dana-Farber Cancer Institute RJ Corman Professor of Medicine Harvard Medical School Boston, Massachusetts Prostate Cancer Emmanuel S Antonarakis, MD Clark Endowed Professor of Medicine Division of Hematology, Oncology and Transplantation University of Minnesota Minneapolis, Minnesota Rana R McKay, MD Associate Professor of Medicine and Urology Associate Director, Translational Sciences Interim Associate Director, Clinical Sciences Co-Lead, Genitourinary Oncology Program University of California San Diego Moores Cancer Center La Jolla, California Renal Cell Carcinoma Brian Rini, MD Professor of Medicine Chief of Clinical Trials Vanderbilt-Ingram Cancer Center Division of Hematology/Oncology Vanderbilt University Medical Center Nashville, Tennessee Additional faculty to be announced Urothelial Bladder Cancer Matthew D Galsky, MD Professor of Medicine Icahn School of Medicine at Mount Sinai Co-Leader, Bladder Cancer Center of Excellence Associate Director, Translational Research The Tisch Cancer Institute New York, New York Jonathan E Rosenberg, MD Chief, Genitourinary Medical Oncology Service Division of Solid Tumor Oncology Enno W Ercklentz Chair Memorial Sloan Kettering Cancer Center New York, New York Moderator Neil Love, MD Research To Practice Miami, Florida Friday to Sunday, March 22–24, 2024 Full agenda and speaker information will be made available later this year. Times and schedule are subject to change. Preliminary Agenda (Eastern Time) Friday, March 22nd Saturday, March 23rd Sunday, March 24th Target Audience JW Marriott Miami Turnberry Meeting Room Room Reservations Parking
This activity has been designed to meet the educational needs of medical oncologists, hematologists, hematology-oncology fellows, nurse practitioners, clinical nurse specialists and other allied cancer professionals.
In-Person Registration Fees This event is free of charge for practicing physicians, fellows, nurses and other healthcare providers involved in the treatment of cancer. For all other individuals, including industry professionals,* a conference registration fee of $1,000 is available through February 24, 2024 and then $1,250 after that day. All fees processed will be nonrefundable after January 31, 2024 (5:00 PM eastern time). To cancel your registration, please contact our Meeting Services department at Meetings@ResearchToPractice.com or call (800) 233-6153. * Individuals employed by for-profit organizations, including financial institutions and biotech or pharmaceutical companies. IN-PERSON Registration for clinicians in practice/healthcare professionals
I am a practicing physician, fellow, nurse or other healthcare provider involved in the treatment of cancer. IN PERSON Registrationfor clinicians » IN-PERSON Registration for other/industry professionals*
Please note, a limited number of seats are available to other/industry professionals on a first come, first served basis. IN PERSON Registrationfor non-clinicians »
* Individuals employed by for-profit organizations, including financial institutions, biotech or pharmaceutical companies
LIVE WEBCAST Registration for all professionals
This activity will also be streamed live via Zoom. Information on how to register for the virtual option will be made available later this year. Please check back for details. Registration for groups
If you are registering a group (more than 1 person) for this event, please contact us at
Meetings@ResearchToPractice.com or (800) 233-6153.
To ensure seating and meal service, please check in at our onsite registration desk at least 30 minutes before the start of the meeting. We cannot guarantee seating after the start of the program.Photography and/or video recording may be taken during the educational program by Research To Practice and used in future educational offerings. Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153. If you have any questions, please feel free to contact us via email at Meetings@ResearchToPractice.com, or call (800) 233-6153. |